Product Description
Overall, the global bone cement market was valued at over $448 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach nearly $556 million.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Bone Cement Market Insights 
The bone cement market is fragmented with multiple companies around the globe competing for market share. With the high number of companies, competitive pricing has emerged, resulting in a declining global ASP that will limit market value growth.
Global Bone Cement Market Share Insights 
- Stryker led the global bone cement market in 2023, driven by the success of its Simplex P™ brand. With ongoing product development, Stryker is expected to maintain its leadership in the coming years.
- Heraeus ranked second, offering the popular PALACOS® antibiotic bone cement. As demand for antibiotic bone cement grows, Heraeus is poised to increase its market share.
- Zimmer Biomet was the third-leading competitor, with products like Refobacin®, Biomet Bone Cement R, and Conflow Bone Cements. Their former flagship, Cobalt™, was divested to Enovis in 2015.
Market Segmentation Summary
- Premixed Antibiotic Market
- Traditional Bone Cement Products Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 220-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |

